Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,425 | 13,855 | 12,156 | 28,535 | 9,216 |
| Receivables | 36,173 | 37,644 | 38,010 | 40,907 | 40,639 |
| Income taxes - deferred | 2,705 | 2,704 | 1,924 | 1,924 | 1,943 |
| Other current assets | 10,283 | 7,217 | 9,766 | 6,671 | 9,059 |
| TOTAL | $61,979 | $63,615 | $64,377 | $80,991 | $60,857 |
| Non-Current Assets | |||||
| PPE Net | 309,190 | 301,531 | 304,420 | 311,026 | 343,568 |
| Investments And Advances | 8,437 | 10,644 | 13,005 | 14,003 | 14,361 |
| Intangibles | 5,471 | 5,806 | 6,103 | 6,608 | 57,292 |
| TOTAL | $323,098 | $317,981 | $323,528 | $331,637 | $415,221 |
| Total Assets | $385,077 | $381,596 | $387,905 | $412,628 | $476,078 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 800 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 26,394 | 29,437 | 25,149 | 32,434 | 41,368 |
| Accrued Expenses | 2,990 | 1,195 | 2,646 | 3,747 | 5,134 |
| TOTAL | $38,953 | $38,543 | $35,364 | $45,237 | $54,610 |
| Non-Current Liabilities | |||||
| Long Term Debt | 174,700 | 175,200 | 190,200 | 208,200 | 219,400 |
| Deferred Revenues | 4,668 | 4,821 | 4,621 | 4,542 | 4,011 |
| TOTAL | $220,124 | $221,149 | $235,413 | $253,601 | $262,900 |
| Total Liabilities | $259,077 | $259,692 | $270,777 | $298,838 | $317,510 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 17,917 | 17,917 | 17,921 | 17,921 | 17,921 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 23,586 | 20,392 | 17,059 | 13,104 | 57,499 |
| Other shareholders' equity | -1,004 | -1,640 | -2,863 | -2,022 | -1,411 |
| TOTAL | $126,000 | $121,904 | $117,128 | $113,790 | $158,568 |
| Total Liabilities And Equity | $385,077 | $381,596 | $387,905 | $412,628 | $476,078 |